Sign in
Taking peopleNo phase

Deep magnetic brain stimulation coils for mild neurocognitive disorder

Tests deep magnetic brain stimulation in people with mild neurocognitive disorder.

Key facts

Who runs it
St. Joseph's Healthcare Hamilton
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Deep rTMS for Mild Neurocognitive Disorder in Older Adults
Status
Recruiting
People taking part
30 people, planned
Started
26 Aug 2025
Expected to end
Jan 2027
Type of study
Interventional, 3 groups
Treatments tested
  • Brainsway H1-Coil Deep TMS System
  • Brainsway H4-Coil Deep TMS System
  • Brainsway H7-Coil Deep TMS System
Record updated
6 October 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for older adults with mild neurocognitive disorder, a mild drop in memory and thinking. It tests three deep brain magnetic stimulation (dTMS) coils.

Age
60 to 90 years
Sex
All sexes
Disease stage
Mild decline in thinking over the past year, noticed by the person, with mild problems on thinking tests. People must still manage daily life on their own and move on their own, for example get in and out of a chair.
Earlier treatment
Doses of other mental health medicines must have been stable for at least 4 weeks before screening. People who currently use bupropion cannot join. People who take more benzodiazepine than equal to lorazepam >2 mg/day cannot join.

Main reasons for not taking part

  • Bipolar disorder or psychotic disorder being treated or needing treatment, active suicidal behavior, or severe depression or anxiety
  • Other brain or mental health conditions that explain the thinking problems
  • Metal implants in or near the head that cannot be safely removed, a pacemaker or implanted defibrillator
  • History of epilepsy or seizures, weekly or more frequent migraines or headaches, or frequent dizziness
  • Substance use disorder (other than tobacco) in the past 3 months, or living outside the Greater Hamilton Area and nearby areas

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • 60 - 90 years old
  • Able to provide informed consent to participate in the study
  • Subjective concern of mild decline in cognitive function over the past year
  • Mild impairment in cognitive performance
  • Preserved independence in everyday activities
  • Independently mobile (e.g., participants must be able to get in and out of a chair on their own)
  • Participants will be required to be on stable dosages of other psychotropic medications for at least 4 weeks prior to screening

Who cannot take part

  • Currently receiving treatment or subjective need for treatment for bipolar I or II disorder; psychotic disorder
  • Substance use disorder (other than tobacco use disorder) in the past 3 months before entering the study
  • Other neurological or psychiatric disorders accounting for the cognitive deficits
  • Impairment in basic and/or instrumental activities of daily living
  • Traditional contraindications to rTMS: Intracranial or metal implants in the head or nearby regions, excluding the mouth, that cannot be safely removed; History of epilepsy or seizures; Active unstable medical condition (recent laboratory and neuroimaging alterations, delirium); Pacemaker and/or implantable cardioverter-defibrillators; current use of bupropion, treatment with equivalent benzodiazepine dose to lorazepam >2 mg/day
  • Active suicidal behavior
  • Severe depression and/or anxiety
  • People with severe literacy, visual, or hearing issues that affect the ability to engage in the interviews
  • People with recurring migraines or headaches (weekly or more)
  • Frequent dizziness/vertigo
  • Individuals residing beyond the borders of the Greater Hamilton Area and its neighbouring vicinities

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 60 and 90 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to: (1) assess the feasibility and tolerability of three deep transcranial magnetic stimulation (dTMS) coils H1, H4, and H7 in older adults with mild neurocognitive disorder (mild NCD); and (2) evaluate changes in cognition through neuropsychological testing, brain activity through EEG, and mood and sleep through self-report questionnaires. Participants will be assigned to one of three arms: H1- coil vs. H4-coil vs. H7-coil, and all participants will complete assessments examining dTMS side effects, mental health symptoms, and cognition. EEG, questionnaires, and CNS vital signs will be measured at baseline, midpoint (after 10th session- before dTMS treatment on visit 11), and end point, as well as follow up. Collectively, the study will address the absolute and differential feasibility and tolerability of the H1, H4 and H7 coils to provide preliminary data for a future randomized controlled trial comparing this novel intervention to a sham stimulation (placebo) control.

The 3 groups in the trial

  • Active H1-coil dTMS treatmentTreatment being tested

    This arm will receive dTMS treatment through active H1-coil.

    Treatment: Brainsway H1-Coil Deep TMS System

  • Active H4-coil dTMS treatmentTreatment being tested

    This arm will receive dTMS treatment through active H4-coil.

    Treatment: Brainsway H4-Coil Deep TMS System

  • Active H7-coil dTMS treatmentTreatment being tested

    This arm will receive dTMS treatment through active H7-coil.

    Treatment: Brainsway H7-Coil Deep TMS System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Feasibility and Tolerability of Deep Repetitive Transcranial Magnetic Stimulation for Mild Neurocognitive Disorder in Older Adults: A Pilot Study (DeepMIND)
Plain-language title
Deep magnetic brain stimulation coils for mild neurocognitive disorderGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT07038798, who can take part
Record updated
6 October 2025